Skip to main content
OpenTrials

Clinical trial condition

Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer

Explore clinical trials studying Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer trial results

Active, Not Recruiting

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

NCT04482309

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Muncie, Indiana, United States
View all 89 locations
View Trial Details

Related conditions